Watch ODYY. Know when insiders buy.
One email the day a filing lands. Free.
ODYY
Odyssey Health, Inc.
0.01
+0.00 +0.00%
USD · close Sep 24
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$3.6MNET CASH $3K52W 0.00 – 0.10SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q3 2026 · Apr 30 | — | — | — | −$298K | $766K | — | 0.01 | −$319K | — | — | Jun 12 |
| Q2 2026 · Jan 31 | — | — | — | −$182K | −$3.6M | — | -0.03 | −$284K | — | — | Jun 12 |
| Q1 2026 · Oct 31 | — | — | — | −$303K | −$483K | — | 0.00 | −$284K | — | — | Jun 12 |
| Q4 2025 · Jul 31derived | — | — | — | −$156K | −$252K | — | -0.01 | −$48K | — | — | Oct 29 |
| Q3 2025 · Apr 30 | — | — | — | −$129K | −$252K | — | 0.00 | −$4K | — | — | Jun 12 |
| Q2 2025 · Jan 31 | — | — | — | −$157K | −$220K | −101.7% | 0.00 | −$47K | — | — | Jun 12 |
| Q1 2025 · Oct 31 | — | — | — | −$579K | −$1M | — | -0.01 | −$249K | — | — | Jun 12 |
| Q4 2024 · Jul 31derived | — | — | — | $237K | −$12.7M | — | -0.12 | −$64K | — | — | Oct 29 |
| Q3 2024 · Apr 30 | — | — | — | −$372K | −$842K | — | -0.01 | −$184K | — | — | Jun 13 |
| Q2 2024 · Jan 31 | — | — | — | −$1.2M | $13.3M | — | 0.12 | −$908K | — | — | Jun 13 |
| Q1 2024 · Oct 31 | — | — | — | −$347K | −$538K | — | -0.01 | −$60K | — | — | Jun 13 |
| Q4 2023 · Jul 31derived | — | — | — | −$655K | −$814K | — | -0.01 | −$120K | — | — | Nov 13 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Jul 31 | — | — | −$1M | −$1.7M | — | -0.02 | −$347K | — | — | — | — |
| FY2024 · to Jul 31 | — | — | −$2.1M | −$842K | — | -0.01 | −$1.2M | — | — | — | — |
| FY2023 · to Jul 31 | — | — | −$5.3M | −$5.9M | — | -0.07 | −$1.5M | — | — | — | — |
| FY2022 · to Jul 31 | — | — | −$8.1M | −$8.4M | — | -0.09 | −$1.5M | — | — | — | — |
| FY2021 · to Jul 31 | — | — | −$15.9M | −$16.9M | — | -0.18 | −$3.2M | — | — | — | — |
| FY2020 · to Jul 31 | $0 | — | −$3.8M | −$4.3M | — | -0.05 | −$649K | — | — | — | — |
Every number comes from Odyssey Health, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.